A Case of Leukocytoclastic Vasculitis and Associated Conjunctivitis Following MMR Vaccine Administration

Introduction. Leukocytoclastic vasculitis (LCV) is a small-vessel vasculitis characterized by immune complex deposition in the walls of dermal capillaries and venules. With the COVID-19 pandemic, more adults are receiving the MMR vaccine, as it may enhance innate immune responses against COVID-19 in...

Full description

Saved in:
Bibliographic Details
Main Authors: Hana I. Nazir, Aubrey A. Hess, Abha Soni, Kathryn A. Potter
Format: Article
Language:English
Published: Wiley 2023-01-01
Series:Case Reports in Dermatological Medicine
Online Access:http://dx.doi.org/10.1155/2023/9001287
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832551156000227328
author Hana I. Nazir
Aubrey A. Hess
Abha Soni
Kathryn A. Potter
author_facet Hana I. Nazir
Aubrey A. Hess
Abha Soni
Kathryn A. Potter
author_sort Hana I. Nazir
collection DOAJ
description Introduction. Leukocytoclastic vasculitis (LCV) is a small-vessel vasculitis characterized by immune complex deposition in the walls of dermal capillaries and venules. With the COVID-19 pandemic, more adults are receiving the MMR vaccine, as it may enhance innate immune responses against COVID-19 infection. Here, we report a case of LCV and associated conjunctivitis arising in a patient secondary to immunization with the MMR vaccine. Methods and Results. A 78-year-old man on lenalidomide therapy for multiple myeloma presented to an outpatient dermatology clinic with a two-day history of a painful rash consisting of scattered pink dermal papules on bilateral dorsal and palmar hands, as well as bilateral conjunctival erythema. Histopathological findings—which revealed an inflammatory infiltrate with papillary dermal edema, as well as nuclear dust within small blood vessel walls with extravasation of red blood cells—were most consistent with LCV. It then became known that the patient had received an MMR vaccine two weeks prior to the onset of the rash. The rash was resolved with the use of topical clobetasol ointment, and the patient’s eyes were cleared as well. Conclusions. This is an interesting presentation of MMR vaccine-related LCV occurring only on the upper extremities with associated conjunctivitis. Had the patient’s oncologist not known about the recent vaccination, it is likely that the treatment of his multiple myeloma would have been postponed or altered, as lenalidomide can also cause LCV.
format Article
id doaj-art-f264f806415243a6af2a4825959f463f
institution Kabale University
issn 2090-6471
language English
publishDate 2023-01-01
publisher Wiley
record_format Article
series Case Reports in Dermatological Medicine
spelling doaj-art-f264f806415243a6af2a4825959f463f2025-02-03T06:04:52ZengWileyCase Reports in Dermatological Medicine2090-64712023-01-01202310.1155/2023/9001287A Case of Leukocytoclastic Vasculitis and Associated Conjunctivitis Following MMR Vaccine AdministrationHana I. Nazir0Aubrey A. Hess1Abha Soni2Kathryn A. Potter3Medical College of GeorgiaMedical College of GeorgiaContra Costa Pathology AssociatesMedical College of GeorgiaIntroduction. Leukocytoclastic vasculitis (LCV) is a small-vessel vasculitis characterized by immune complex deposition in the walls of dermal capillaries and venules. With the COVID-19 pandemic, more adults are receiving the MMR vaccine, as it may enhance innate immune responses against COVID-19 infection. Here, we report a case of LCV and associated conjunctivitis arising in a patient secondary to immunization with the MMR vaccine. Methods and Results. A 78-year-old man on lenalidomide therapy for multiple myeloma presented to an outpatient dermatology clinic with a two-day history of a painful rash consisting of scattered pink dermal papules on bilateral dorsal and palmar hands, as well as bilateral conjunctival erythema. Histopathological findings—which revealed an inflammatory infiltrate with papillary dermal edema, as well as nuclear dust within small blood vessel walls with extravasation of red blood cells—were most consistent with LCV. It then became known that the patient had received an MMR vaccine two weeks prior to the onset of the rash. The rash was resolved with the use of topical clobetasol ointment, and the patient’s eyes were cleared as well. Conclusions. This is an interesting presentation of MMR vaccine-related LCV occurring only on the upper extremities with associated conjunctivitis. Had the patient’s oncologist not known about the recent vaccination, it is likely that the treatment of his multiple myeloma would have been postponed or altered, as lenalidomide can also cause LCV.http://dx.doi.org/10.1155/2023/9001287
spellingShingle Hana I. Nazir
Aubrey A. Hess
Abha Soni
Kathryn A. Potter
A Case of Leukocytoclastic Vasculitis and Associated Conjunctivitis Following MMR Vaccine Administration
Case Reports in Dermatological Medicine
title A Case of Leukocytoclastic Vasculitis and Associated Conjunctivitis Following MMR Vaccine Administration
title_full A Case of Leukocytoclastic Vasculitis and Associated Conjunctivitis Following MMR Vaccine Administration
title_fullStr A Case of Leukocytoclastic Vasculitis and Associated Conjunctivitis Following MMR Vaccine Administration
title_full_unstemmed A Case of Leukocytoclastic Vasculitis and Associated Conjunctivitis Following MMR Vaccine Administration
title_short A Case of Leukocytoclastic Vasculitis and Associated Conjunctivitis Following MMR Vaccine Administration
title_sort case of leukocytoclastic vasculitis and associated conjunctivitis following mmr vaccine administration
url http://dx.doi.org/10.1155/2023/9001287
work_keys_str_mv AT hanainazir acaseofleukocytoclasticvasculitisandassociatedconjunctivitisfollowingmmrvaccineadministration
AT aubreyahess acaseofleukocytoclasticvasculitisandassociatedconjunctivitisfollowingmmrvaccineadministration
AT abhasoni acaseofleukocytoclasticvasculitisandassociatedconjunctivitisfollowingmmrvaccineadministration
AT kathrynapotter acaseofleukocytoclasticvasculitisandassociatedconjunctivitisfollowingmmrvaccineadministration
AT hanainazir caseofleukocytoclasticvasculitisandassociatedconjunctivitisfollowingmmrvaccineadministration
AT aubreyahess caseofleukocytoclasticvasculitisandassociatedconjunctivitisfollowingmmrvaccineadministration
AT abhasoni caseofleukocytoclasticvasculitisandassociatedconjunctivitisfollowingmmrvaccineadministration
AT kathrynapotter caseofleukocytoclasticvasculitisandassociatedconjunctivitisfollowingmmrvaccineadministration